文献速递临床试验与 GCP医学教育与科研方法

简短动力人际心理治疗对重性抑郁障碍疗效:前瞻性多中心随机对照试验方案

Efficacy of brief dynamic interpersonal therapy in patients with major depressive disorder: a prospective, multicenter randomized controlled trial protocol.
PubMed 文献 · Trials · 2020-07-23

主要结局为17项汉密尔顿抑郁量表基线变化,由盲法独立评定者评估,旨在评估简短心理动力干预对中国重性抑郁障碍患者的疗效。

要点

  • 中国首个多中心RCT评估简短心理动力干预对重性抑郁障碍的疗效。
  • 主要结局为17项汉密尔顿抑郁量表基线变化,由盲法独立评定者评估。

核心结论

  • 该研究将是中国首个评估简短心理动力干预治疗重性抑郁障碍疗效的多中心随机对照试验。
  • 研究结果有潜力为中国抑郁症治疗临床指南提供信息。

研究设计与样本

  • 患者按1:1:1随机分配至药物联合DIT、药物联合活性对照心理治疗或单用药物三组。
  • 评估时间点为基线、急性治疗期第2、4、8、12、16周及治疗后1、3、6、12个月。
  • 主要结局由对治疗分配盲法的独立评定者使用17项汉密尔顿抑郁量表评估。

关键数值与推荐

  • 主要结局为17项汉密尔顿抑郁量表基线变化。
  • 次要指标包括汉密尔顿焦虑量表、患者健康问卷-9、广泛性焦虑障碍7项量表、应答率、缓解率、复发率、患者整体疗效与满意度自评及副作用特征。

临床怎么用

  • 若证实有效,简短动力人际心理治疗可作为中国重性抑郁障碍患者的治疗选择,并为临床指南提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In China, psychodynamic psychotherapies are widely used as a treatment for depression. However, very few efficacy studies of psychodynamic therapies have been conducted with the Chinese population. This paper describes a study protocol of a multicenter randomized controlled trial of dynamic interpersonal psychotherapy (DIT), a brief manualized depression-focused intervention, in Chinese adults with major depressive disorder (MDD). METHODS: Recruitment is planned in five hospitals. Two hundred forty patients with MDD will be randomly allocated on a 1:1:1 basis to either medication plus DIT, medication plus an active control psychotherapy, or medication alone. Patients will be assessed at baseline and at weeks 2, 4, 8, 12, and 16 during the acute treatment phase and 1, 3, 6, and 12 months posttreatment. The primary outcome is change from baseline in the 17-item Hamilton Depression Rating Scale, administered by independent raters who are blind to treatment allocation. The Hamilton Anxiety Rating Scale, Patient Health Questionnaire-9, Generalized Anxiety Disorder 7-item scale, response, remission and relapse rates, self-assessment of overall efficacy and satisfaction of patients, and side effect profiles are secondary measures. DISCUSSION: This will be the first multicentered RCT in China to assess the efficacy of a brief psychodynamic intervention for MDD. The study has the potential to inform clinical treatment guidelines for the treatment of depression in China. TRIAL REGISTRATION: ChiCTR, ChiCTR1800016970 . Registered on July 5, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang L, Wang Q, Jiang W, et al. Efficacy of brief dynamic interpersonal therapy in patients with major depressive disorder: a prospective, multicenter randomized controlled trial protocol. Trials. 2020. PMID: 32703316. doi:10.1186/s13063-020-04569-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。